Skip to main content
. 2022 Oct 27;26:330. doi: 10.1186/s13054-022-04199-3

Table 2.

Hospitalization characteristics, procedures and cause of death

Parameter Prehospital ROSC (n = 83) No ROSC and ACLS (n = 81) No ROSC and ECPR (n = 92) P value
Admitted to the hospital 83 (100%) 35 (43.2%) 92 (100%) < 0.001
Achieved ROSC 83 (100%) 9 (11.1%) NA 0.002
Laboratory on admission
 pH 7.13 (7–7.19) 6.85 (6.75–6.91) 6.86 (6.75–6.98)  < 0.001
 Lactate (mmol/L) 8.2 (6.2–11.5) 13.6 (11.1–17.5) 13.7 (10.95–17.0) < 0.001
ECLS therapy 1 (1.2%)* 0 92 (100%)** < 0.001
TTM used 78 (94%) 10 (28.6%) 90 (97.8%) < 0.001
Coronary angiography 78 (94%) 14 (40%) 89 (97.8%)  < 0.001
PCI 37 (47.4%) 4 (28.6%) 51 (57.3%) 0.1
 Successful 31 (83.8%) 2 (50%) 47 (92.2%) 0.04
 Unsuccessful 6 (16.2%) 2 (50%) 4 (7.8%)
Cause of death
 Refractory arrest 1 (2.9%) 72 (90%) 7 (9.9%) < 0.001
 Brain death 9 (26.5%) 2 (2.5%) 19 (26.8%)
 MODS 17 (50%) 4 (5%) 31 (43.7%)
 Cardiogenic shock 3 (8.8%) 1 (1.3%) 10 (14.1%)
 UNK 4 (11.8%) 0 (0%) 1 (1.4%)
 Bleeding 0 (0%) 1 (1.3%) 3 (4.2%)
WLST 13 (15.7%) 2 (2.5%) 20 (21.7%)  < 0.001
Complications
 Bleeding—any*** 5 (6.1%) 1 (8.3%) 40 (44%)  < 0.001
  Fatal 0 (0%) 1 (100%) 3 (7.5%) 0.03
  Intracranial 1 (20%) 0 (0%) 9 (22%)
  Overt 4 (80%) 0 (0%) 28 (70%)
 Organ lacerations 2 (2.7%) 2 (3.3%) 3 (3.6%) 0.95
 Technical 0 (0%) 0 (0%) 3 (3.3%) 0.07
Length of ICU stay (days)
 Survivors 11 (8–15) 5 (5–5) 16 (11–29) 0.007
 Deceased 6 (2–9.5) 1 (1–1) 3 (2–8)  < 0.001

Highlighted in bold are the values which are statistically significant (less than 0.05)

*ECLS therapy indicated during hospitalization for arrhythmic storm with cardiogenic shock

**ECLS therapy indicated for refractory OHCA (ECPR)

***Bleeding complications were assessed based on Thrombolysis in Myocardial Infarction classification under “major” category, defined as any intracranial hemorrhage (excluding microhemorrhages < 10 mm), fatal bleeding directly resulting in death within 7 days or overt bleeding associated with a decrease in hemoglobin concentration of 5 g/dL or a 15% absolute decrease in hematocrit

ACLS advanced cardiac life support, ECLS extracorporeal life support, ECPR extracorporeal cardiopulmonary resuscitation, ICU intensive care unit, MODS multiple organ dysfunction syndrome, NA not applicable, PCI percutaneous coronary intervention, ROSC return of spontaneous circulation, TTM target therapeutic management, UNK unknown, WLST withdrawal of life-sustaining therapy